Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 67 clinical trials
featured
EINSTEIN CHOICE

EINSTEIN CHOICE

  • 352 views
  • 08 Nov, 2020
  • 1 location
Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion

support the use of intraprocedural anticoagulation to mitigate the risk of radial artery occlusion however the role of post-procedural anticoagulation has not been previously evaluated. Rivaroxaban is a

  • 11 views
  • 26 Jan, 2021
  • 1 location
A Study of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events Hospitalization and Death in Medically Ill Outpatients With Acute Symptomatic Coronavirus Disease 2019 (COVID-19) Infection

The purpose of this study is to evaluate whether rivaroxaban reduces the risk of a composite endpoint of major venous and arterial thrombotic events, all-cause hospitalization, and all-cause

nasopharyngeal swab
cancer
coronavirus infection
covid-19
ageusia
  • 0 views
  • 17 Jan, 2021
  • 13 locations
Study of Rivaroxaban for CeREbral Venous Thrombosis

SECRET examines the safety of rivaroxaban versus standard-of-care for treatment of symptomatic cerebral venous thrombosis, initiated within 14 days of diagnosis.

  • 1 views
  • 25 Jan, 2021
  • 13 locations
Rivaroxaban or Aspirin for Biological Aortic Prosthesis

recipient endothelium. There are no conclusive studies of anticoagulation and the investigators have shown stroke to be a common complication. Guidelines have variably recommended aspirin or rivaroxaban for

aspirin
rivaroxaban 10 mg
infarct
stroke
clot
  • 0 views
  • 22 Jan, 2021
  • 3 locations
Early Rivaroxaban for Acute Ischemic Stroke or TIA Patients With Atrial Fibrillation

> Rivaroxaban, a direct coagulation factor a inhibitor, blocks the formation of the clot. ROCKET-AF study has shown that the efficacy of rivaroxaban is not inferior to that of warfarin in AF patients on stroke

deficit
anticoagulant therapy
anticoagulants
infarct
warfarin
  • 13 views
  • 23 Jan, 2021
  • 1 location
Treatment of Cardiovascular Disease With Low Dose Rivaroxaban in Advanced Chronic Kidney Disease

provide comprehensive CKD care. Approximately 2000 participants will be recruited. The TRACK trial will assess a strategy of administering low dose rivaroxaban to reduce the risk of major adverse

  • 0 views
  • 02 Jan, 2021
  • 20 locations
Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism

Apixaban and rivaroxaban have been compared to standard therapy for treatment of acute symptomatic venous thromboembolism (VTE) in randomized controlled trials (RCTs), and are both approved by

venous thromboembolism
apixaban
probe
rivaroxaban
anticoagulants
  • 285 views
  • 18 Jan, 2021
  • 21 locations
Rivaroxaban for the Treatment of Symptomatic Isolated Distal Deep Vein Thrombosis

isolated distal deep vein thrombosis of the leg treated with a standard (12 weeks) or with a shorter (6 weeks) duration of therapy with rivaroxaban.

deep vein thrombosis
venous thromboembolism
heparin
clot
rivaroxaban
  • 23 views
  • 22 Jan, 2021
  • 7 locations
Prophylactic Anticoagulation for Catheter-related Thrombosis

The main objective of this study is to compare the efficacy and safety of aspirin, low molecule heparin and rivaroxaban for preventing catheter-related thrombosis in middle-to-high-risk

  • 0 views
  • 25 Jan, 2021
  • 17 locations